Dioxygenase mutants and use thereof in synthesizing (2S,3R)-3-hydroxypipecolic acid
By mutating arginine at position 97 and asparagine at position 43 of a wild type L-proline-3-hydroxylase, a mutated L-proline-3-hydroxylase is obtained. The mutated L-proline-3-hydroxylase comprises a variant of the wild-type L-proline-3-hydroxylase having SEQ ID NO:1, which comprises a substitution of the arginine corresponding to position 97 (R97) of SEQ ID NO:1 and a substitution of the asparagine corresponding to position 43 (N43) of SEQ ID NO:1; wherein the amino acid substituted into the mutated L-proline-3-hydroxylase at position R97 is methionine, and wherein the amino acid substituted into the mutated L-proline-3-hydroxylase at position N43 is selected from the group consisting of threonine (T), alanine (A), valine (V), serine(S), aspartic acid (D), and lysine (K).
1. A mutated L-proline-3-hydroxylase comprising a variant of the wild-type L-proline-3-hydroxylase having SEQ ID NO:1, which comprises a substitution of the arginine corresponding to position 97 (R97) of SEQ ID NO:1 and a substitution of the asparagine corresponding to position 43 (N43) of SEQ ID NO: 1;
wherein the amino acid substituted into the mutated L-proline-3-hydroxylase at position R97 is methionine, and
wherein the amino acid substituted into the mutated L-proline-3-hydroxylase at position N43 is selected from the group consisting of threonine (T), alanine (A), valine (V), serine(S), aspartic acid (D), and lysine (K).
2. A microbial cell expressing the mutated L-proline-3-hydroxylase according to claim 1 , or containing a gene encoding the mutated L-proline-3-hydroxylase, or containing a recombinant vector comprising a gene encoding the mutated L-proline-3-hydroxylase.
3. The microbial cell according to claim 2 , wherein the microbial cell comprises a host cell and the host cell is bacteria or fungi.
4. The microbial cell according to claim 3 , wherein the microbial cell comprises a host cell and the host cell is Escherichia coli, Bacillus subtilis , or yeast.
5. A method for preparing (2S,3R)-3-hydroxypipecolic acid, comprising: adding the mutated L-proline-3-hydroxylase according to claim 1 to a reaction system containing L-pipecolic acid, preparing and obtaining the (2S,3R)-3-hydroxypipecolic acid.
6. The method according to claim 5 , wherein the reaction system comprises L-pipecolic acid, α-ketoglutaric acid, L-ascorbic acid, and FeSO 4 ·7H 2 O.
7. The method according to claim 6 , wherein the method comprises: adding 100 μL of crude enzyme of the mutated L-proline-3-hydroxylase to 150 L of the reaction system and obtaining a final reaction system; wherein the final reaction system contains comprises 10 mM substrate L-pipecolic acid, 15 mM to 30 mM α-ketoglutaric acid is, 10 mM to 20 mM L-ascorbic acid, up to 0.10 mM FeSO 4 ·7H 2 O; the final reaction system has a total volume of 250 μL; and the reaction is carried out at 10° C. and pH of 6.5 for 12 hours.
8. The method according to claim 7 , wherein the final reaction system comprises 10 mM substrate L-pipecolic acid, 30 mM α-ketoglutaric acid, 15 mM L-ascorbic acid, and 0.05 mM FeSO 4 ·7H 2 O; the final reaction system has a total volume of 250 μL; and the reaction is carried out at 10° C. and pH of 6.5 for 12 hours.